Catellani, S., Pierri, I., Gobbi, M., Poggi, A., & Zocchi, M. R. (2011). Imatinib treatment induces CD5+ B lymphocytes and IgM natural antibodies with anti-leukemic reactivity in patients with chronic myelogenous leukemia. Public Library of Science (PLoS).
Cita Chicago Style (17a ed.)Catellani, Silvia, Ivana Pierri, Marco Gobbi, Alessandro Poggi, y Maria Raffaella Zocchi. Imatinib Treatment Induces CD5+ B Lymphocytes and IgM Natural Antibodies with Anti-leukemic Reactivity in Patients with Chronic Myelogenous Leukemia. Public Library of Science (PLoS), 2011.
Cita MLA (8a ed.)Catellani, Silvia, et al. Imatinib Treatment Induces CD5+ B Lymphocytes and IgM Natural Antibodies with Anti-leukemic Reactivity in Patients with Chronic Myelogenous Leukemia. Public Library of Science (PLoS), 2011.